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High glucose evokes an intrinsic proapoptotic signaling pathway
in mesangial cells.
Background. In response to chronic hyperglycemia, mi-
crovascular cells undergo stress and injury, which can lead to
cell death. We characterized a proapoptotic signaling pathway
whereby high glucose evokes an intrinsic, caspase-9–dependent
mechanism of cell death in human mesangial cells.
Methods. Biochemical (caspase activity, cytochrome-c re-
lease, etc.) and morphologic (chromatin condensation and
nuclear segmentation) features of apoptotic cell death were
assessed in cultured human mesangial cells exposed to high
glucose, a risk factor for mesangial cell injury and diabetic
glomerulosclerosis. Proapoptotic signaling was also analyzed in
the db/db murine model of kidney injury in diabetes.
Results. Incubation in high glucose caused cytotoxicity and
apoptosis in mesangial cells. High glucose stimulated mitochon-
drial release of cytochrome-c, cleavage of procaspase-9, and
caspase-9 enzyme activity, suggesting an intrinsic pathway of
proapoptotic signaling. In contrast, caspase-8 was unaffected
by high glucose. A cell-permeable, caspase-9-selective inhibitor
blocked caspase-3 activation and prevented chromatin con-
densation and nuclear segmentation in cells treated with high
glucose. To determine whether an intrinsic signaling pathway
occurs in the diabetic kidney in vivo, apoptosis was investi-
gated in diabetic 8- and 16-week db/db murine kidneys. Effector
caspases-3 and -7 were activated in diabetic db/db kidneys but
not in age-matched nondiabetic db/m controls. At 16 weeks,
apoptotic cells in db/db glomeruli were identified on the basis
of nuclear segmentation and DNA fragmentation. Apoptosis of
glomerular cells correlated with expansion of the mesangial ma-
trix and with worsening of albuminuria. Consistent with an in-
trinsic signaling pathway, caspase-9 cleavage was elevated only
in db/db kidneys, whereas activation of caspase-8 and caspase-
12 was undetectable.
Conclusion. These findings support the hypothesis that hy-
perglycemia evokes an intrinsic pathway of proapoptotic sig-
naling in mesangial cells. In addition, these results point to an
important role for the intrinsic pathway in microvascular injury
in the diabetic kidney in vivo.
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Microvascular injury occurs in all forms of diabetes
and is thought to be caused principally by hyperglycemia
(reviewed in [1–4]). Diabetes-specific microvascular in-
jury in the kidney occurs in the glomerulus, which is
an important step in developing diabetic nephropathy.
In the renal glomerulus, mesangial cells are prone to
hyperglycemia-induced cell stress and injury [5–8]. Sev-
eral mechanisms have been proposed to explain mesan-
gial injury by hyperglycemia, including hyperfiltration,
abnormal vascular permeability, production of inflamma-
tory cytokines and growth factors, formation of advanced
glycation end products (AGEs), and increased oxidative
stress. More recently, chronic hyperglycemia has been
proposed to cause mesangial injury by evoking pathways
leading to apoptotic cell death. Indeed, hyperglycemia-
induced apoptosis might be an important pathogenic fac-
tor in other forms of microvascular injury in diabetes [1,
2, 4].
Although the ability of hyperglycemia to induce apop-
tosis in mesangial cells has not been widely studied, Kang
et al [9] reported that high glucose stimulates caspase-
3 cleavage and DNA fragmentation in cultured human
mesangial cells. Apoptosis of cultured mesangial cells is
induced by AGEs [10], which have been implicated in
hyperglycemia-induced diabetic microvascular complica-
tions. Mesangial cell apoptosis in these studies was at-
tenuated by the antioxidant N-acetylcysteine, implicating
oxidative stress induced by the AGEs [10]. Two addi-
tional hyperglycemia-related diabetic stressors, methyl-
glyoxal [11] and transforming growth factor-b (TGF-b)
[12], have also been shown to induce apoptosis in cultured
mesangial cells.
Clinical studies in patients with type 2 diabetic
nephropathy report a loss of glomerular mesangial cells
and podocytes that correlates with progression to dia-
betic glomeruloslcerosis [13–16]. Depletion of mesangial
cells has been noted in segments of the glomerular tuft
where expansion of the mesangial matrix has occurred [8,
15, 17–19]. In one study, the loss of mesangial cells even
correlates with the development of incipient nephropa-
thy and with significant structural changes resulting in
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the loss of single nephron Kf [15]. These clinical studies
did not address the mechanisms of glomerular cell death,
but other studies of microvascular injury in diabetes have
associated hyperglycemia with apoptotic death of mi-
crovascular cells in diabetes [1, 2, 4]. So it seems possible
that hyperglycemia-induced apoptosis might contribute
to mesangial cell injury, but the pathways of apoptotic
signaling evoked by hyperglycemia are unclear.
In this study, we investigated the pathways of proapop-
totic signaling activated in mesangial cells exposed to high
glucose. We report here that high glucose causes apop-
tosis in human mesangial cells and activates a caspase-9–
dependent intrinsic pathway of proapoptotic signaling.
In addition, we observed an intrinsic pathway of apop-
totic signaling in db/db diabetic mouse kidneys in vivo
and apoptosis of cells in the glomerular microvascula-
ture. Taken together, these results suggest an important
role for hyperglycemia-induced proapoptotic signaling in
microvascular cell injury in diabetes.
METHODS
Reagents
Antibodies used in these studies for Western blot-
ting were from Cell Signaling (Beverly, MA, USA) ex-
cept where indicated: caspase-3 active fragment (9661),
caspase-3 total (9668), caspase-7 active fragment (9491),
murine-specific pro- and active fragment caspase-9
(9504), human-specific pro- and active fragment of
caspase-9 (9502), murine-specific pro- and cleaved
caspase-12 (2202), Bax (2772), human cytochrome-c
(4272), murine and human pro- and active fragment
caspase-8 (55932) (BD Biosciences San Diego, CA,
USA), and b-actin (A5316) (Sigma, St. Louis, MO, USA).
The cell-permeable caspase-9 selective inhibitor, Z-
LEHD-FMK, was from R&D Systems (Minneapolis,
MN, USA).
Human mesangial cell culture and viability assays
Human mesangial cells, purchased from Cambrex Bio-
science, Inc. (Walkersville, MD, USA), were maintained
in Dulbecco’s modified essential medium (DMEM)
(11885) (Gibco-BRL, Gaithersburg, MD, USA), supple-
mented with 17% fetal bovine serum (FBS), 100 U/mL
penicillin, 100 lg/mL streptomycin, 5 ng/mL selenite, and
5 lg/mL each of insulin and transferrin. Characterization
was performed by phase-contrast microscopy and by
immunostaining for intermediate filaments and surface
antigens as described previously [20, 21]. Briefly, cells
were positive for desmin, vimentin, and myosin, but did
not stain for factor VIII, keratin, or common leukocyte
antigen. For glucose activation, cells were plated in
60 mm plates in the DMEM containing 17% FBS. After
24 hours, the medium was changed to DMEM/5%
FBS with 5.5 mmol/L glucose, 30 mmol/L glucose, or
30 mmol/L mannitol and cells were incubated for the
time indicated. If necessary, the medium was changed
every 48 hours to maintain the appropriate concentration
of glucose. For cell viability assays, cells in 24-well plates
were exposed to normal (5.5 mmol/L) or high glucose
(30 mmol/L) exactly as described above, and MTS [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium] reduction was measured
for 30 minutes at 37◦C using a protocol from the man-
ufacturer (G3580) (Promega, Inc., Madison WI, USA)
and recording the absorbance at 490 nm in 96-well plates
using a SpectraMax 190 microplate reader (Molecular
Devices, Sunnyvale CA, USA). Wells with media alone
served as the blank. Release of lactate dehydrogenase
(LDH) into the media was measured enzymatically
(Promega).
Assessment of apoptosis in cultured human mesangial
cells
Western blotting of active caspase fragments in human
mesangial cells was performed as previously reported
by us with minor modification [22]. Briefly, cells were
washed with ice-cold phosphate-buffered saline (PBS)
and scraped in CHAPS extraction buffer [50 mmol/L
Pipes/HCI, pH 6.5, 2 mmol/L ethylenediaminetetraacetic
acid (EDTA), 0.1% CHAPS, 20 lg/mL leupeptin,
10 lg/mL pepstatin A, 10 lg/mL aprotinin, 5 mmol/L
dithiothreitol (DTT), 2 mmol/L sodium pyrophosphate,
1 mmol/L Na3VO4, and 1 mmol/L NaF]. An aliquot
was saved for protein determination using the DC as-
say (Bio-Rad, Hercules, CA, USA). An equal volume
of 2× sodium dodecyl sulfate (SDS) sample buffer was
immediately added to the extraction buffer, and West-
ern blotting was carried out using antibodies for human
caspase-9, caspase-8, and the active fragments of hu-
man caspase-3. As previously described [23], the West-
ern blots were analyzed by densitometry in NIH Image
by normalizing values for the relevant caspase fragment
to the highest value within each experiments (maximum
level = 1). To measure caspase-9 enzyme activity, hu-
man mesangial cells were lysed (20 mmol/L Tris, pH 7.5,
150 mmol/L NaCl, and 1.0% Triton X-100) and equiv-
alent amounts of total human mesangial cells protein
were added to a buffer containing the LEHD caspase-9
peptide substrate linked to a cleavable luciferase sub-
strate, aminoluciferin (Promega). The amount of light
produced in a coupled reaction with luciferase was mea-
sured in a Berthold Luminometer (Berthold, Bad Wilbad,
Germany). To quantify the number of pyknotic nuclei, a
cardinal feature of apoptotic cells, human mesangial cells
on coverslips were washed once with PBS and fixed for
20 minutes with freshly prepared 3.7% formalde-
hyde/20% sucrose in PBS. After washing twice with PBS
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the human mesangial cells were stained with 5 lg/mL
Hoechst 33342 (Molecular Probes, Eugene, OR, USA)
and mounted in Slow Fade Light (Molecular Probes).
The number of pyknotic nuclei were expressed as a per-
centage of the total number of nuclei counted (N =
>300 nuclei per condition). To analyze cytochrome-c re-
distribution, human mesangial cells were fractionated
into cytosol and membrane fractions using 0.05% digi-
tonin in an isotonic sucrose buffer exactly as described
by Dong et al [24]. Because cytochrome-c release oc-
curs mostly from mitochondria, Western blot analysis
of cytosol and membrane fractions is expected to re-
flect cytochrome-c translocation from mitochondria to
the cytoplasm.
Studies in db/db mice: Diabetes and renal
structure/function measurements
This study protocol was approved by the Institutional
Animal Care and Use Committee of Case Western Re-
serve University according to the Guide for the Care and
Use of Laboratory Animals from the National Institutes
of Health. Male db/db (BKS.Cg-m+/+Leprdb) and db/m
mice were used for all studies (Jackson Laboratories, Bar
Harbor, ME, USA). Mice were housed in a sterile envi-
ronment with 12-hour/12-hour light/dark cycles and had
free access to food and water. Blood glucose was mon-
itored using an Accu-Chek meter (Roche Diagnostics,
Indianapolis, IN, USA). To measure 24-hour albumin ex-
cretion, mice were placed in individual mouse diuresis
cages (Nalgene, Rochester, NY, USA) with access to wa-
ter but no food for 24 hours. Following 24-hour ad libitum
access to food and water, the mice were anesthetized and
serum was collected and frozen at −40◦C. Kidney tissue
was rapidly processed for histology or Western blotting
as described below. Serum creatinine was measured using
a kinetic micro-Jaffe´ reaction (10 lL sample) with care
taken to measure only the initial reaction rate to minimize
interference by glucose [25]. However, this assay is bi-
ased by the presence of unidentified noncreatinine chro-
magens in mice [25]. Urinary albumin concentration was
measured with an enzyme-linked immunosorbent assay
(ELISA) specific for mouse albumin (Exocell, Philadel-
phia, PA, USA). At the time of sacrifice, sagittal sections
of kidney were fixed in 10% neutral buffered formalin,
embedded in paraffin, and sectioned at 5 lm. Morphome-
tric analysis of renal structure was conducted using previ-
ously established techniques [8, 26]. The mesangial matrix
fraction was analyzed in coded sections stained with pe-
riodic acid-Schiff (PAS) reagent. Twenty glomeruli from
each of three sections per mouse were imaged. Digital im-
ages for analysis and for photomicroscopy were acquired
with a SPOT CCD camera (Diagnostic Instruments,
Sterling Heights, MI, USA).
In vivo measurements of apoptosis in the glomeruli of
db/db and db/m mice
Several well-established techniques were used to iden-
tify apoptosis in tissue sections [27–29]. First, light mi-
croscopy was used to identify changes characteristic of
apoptotic cells in standard hematoxylin-eosin sections.
These changes include condensation of nuclear chro-
matin to sharply delineated granular masses along the
perimeter of the nuclear envelope (also known as cres-
cent formation), convolution of the cellular and nuclear
outlines with general cell shrinkage, and segmentation
of the nucleus. Terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate (dUTP) nick end
labeling (TUNEL) (R&D Systems) was used to iden-
tify nuclei with DNA fragmentation characteristic of
apoptotic cells. The manufacturer’s instructions were fol-
lowed except that 20 lg/mL of proteinase K (161519)
(Roche Diagnostic) for 30 minutes at 37◦C was used to
achieve adequate permeability of reagents into the nu-
clei of glomeruli. All measurements of TUNEL staining
in db/db kidneys were conducted concurrently with iden-
tically processed db/m controls. We also performed un-
labeled experimental controls [i.e., omission of terminal
deoxynucleotidyl transferase (TdT) enzyme] and posi-
tive controls with nuclease-treated sections in each assay.
The number of TUNEL-positive glomerular cells were
counted blindly in 20 glomeruli from each of three sepa-
rate sections from each mouse. The number of TUNEL-
positive specific glomerular cells was averaged from the
individual glomerular counts (i.e., N = 60 glomeruli per
mouse).
Western blotting for active caspase fragments in db/db
kidney extracts
Western blotting for proteins in db/db kidneys was per-
formed essentially as previously described [23]. Kidney
homogenates (15% wt/vol) were prepared in CHAPS ex-
traction buffer and centrifuged at 2000 × g for 10 minutes
at 4◦C. Protein content in the supernatant was assayed
with the DC protein assay. An aliquot of the lysate (25 lg
protein) was boiled in SDS sample buffer, resolved on
a 4% to 12% SDS-polyacrylamide gel electrophoresis
(PAGE) gradient gel, and transferred to a 0.2 lm nitro-
cellulose membrane. After blocking in 5% nonfat dried
milk in TBS-T (20 mmol/L Tris-Cl, pH 7.5, 150 mmol/L
NaCl, and 0.05% Tween 20) for 1 hour, the membrane was
washed 3 times with TBS-T for 5 minutes each and incu-
bated overnight at 4◦C with primary antibody (1:1,000)
in 3% bovine serum albumin (BSA) in TBS-T. After
incubating with suitable horseradish peroxidase-labeled
secondary antibody (1:2,000) and extensive washing, the
proteins were detected by chemiluminescence with an av-
erage exposure ranging from 10 to 30 seconds. Analysis
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Fig. 1. Cytotoxicity and apoptosis in hu-
man mesangial cells treated with high glu-
cose. (A) Human mesangial cells were plated
in Dulbecco’s modified essential medium
(DMEM) containing 17% fetal bovine serum
(FBS) for 24 hours, after which the medium
was changed to 5% FBS and normal glucose
(NG) (5.5 mmol/L), high glucose (HG) (30
mmol/L), or normal glucose plus 30 mmol/L
mannitol (NGM) were added. The media was
changed every 2 days to maintain the appro-
priate concentrations of glucose or manni-
tol. At the times indicated, cell viability was
measured in an MTS assay. (B) Lactate de-
hydrogenase (LDH) release into the media
by human mesangial cells treated with nor-
mal glucose or high glucose. (C) Western blots
for the active fragments of human caspase-3
(p17 and p19 kD) in human mesangial cells in-
cubated with normal glucose or high glucose.
(D) Densitometric analysis of the combined
p17 and p19 caspase-3 levels from three ex-
periments. (E) Photomicrograph illustrating
morphology of pyknotic nuclei (arrows) (i.e.,
nuclear condensation and segmentation) re-
vealed by Hoechst 33342 staining in human
mesangial cells treated with high glucose for
48 hours (magnification ×600). (F) Percent-
age of pyknotic nuclei identified in human
mesangial cells incubated with normal glucose
or high glucose. (A, B, and D) are mean ±
SEM from three independent experiments.
∗P < 0.05; ∗∗P < 0.01 by t test vs. normal
glucose at same time point. (F) Three experi-
ments. ∗∗P <0.01 by v 2 test vs. normal glucose.
of the results by densitometry using NIH Image was as
described [23].
RESULTS
High glucose stimulates apoptosis in human mesangial
cells
Hyperglycemia is a major risk factor for mesangial
cell injury in vivo, so we determined if hyperglycemia
stimulates apoptosis of cultured human mesangial cells.
As shown in Figure 1A, the proliferative capacity of
human mesangial cells was significantly impaired in
media containing high glucose (30 mmol/L) to mimic
hyperglycemia compared to cells cultured in normal glu-
cose (5.5 mmol/L). After 48 hours of 30 mmol/L glucose,
human mesangial cell proliferation was significantly de-
pressed, an effect that was observed up to 120 hours of
treatment with 30 mmol/L glucose (Fig. 1A). Treatment
of human mesangial cells with mannitol, to control for
possible nonspecific effects of changes in osmolarity on
human mesangial cell viability, demonstrated that the de-
crease in proliferation by high glucose was not due to the
change in osmolarity of the culture medium (Fig. 1A).
Release of LDH into the media, a marker of cytotoxicity,
was significantly increased by high glucose compared to
normal glucose (Fig. 1B). The conclusion from these stud-
ies is that high glucose reduces the proliferative capacity
and viability of cultured human mesangial cells.
We next asked whether high glucose causes apoptosis
in cultured human mesangial cells. The caspase family of
cysteine acid proteases are key regulators of apoptosis.
When activated by apoptotic stimuli, the initiator cas-
pases (8, 9, 10, and 12) cleave and activate downstream
effector caspases (including 3, 6, and 7). Using an anti-
body that selectively detects the p17 kD active fragment
of caspase-3 in Western blots, we found that high glucose
activated caspase-3 at 8, 24, and 48 hours compared to
normal glucose (Fig. 1C and D). In addition, high glu-
cose increased the formation of pyknotic nuclei after 24
and 48 hours compared to incubation in normal glucose
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Fig. 2. High glucose stimulates caspase-9 cleavage in cultured human
mesangial cells. (A) Human mesangial cells treated with normal glucose
(NG) or high glucose (HG) were harvested, and equivalent amounts of
cell protein (P) were analyzed by Western blotting for the cleaved (C)
fragments of human caspase-9 (p35 kD) and caspase-8 (p40 kD). (B)
Densitometric analysis of active caspase-9 fragment levels in Western
blots from three independent experiments. ∗∗P <0.01 by t test vs. normal
glucose at same time point.
(Fig. 1E and F). Thus, using two established criteria for
apoptotic cell death [27–29], we conclude that high glu-
cose stimulates apoptosis in cultured human mesangial
cells.
Proapoptotic signaling in human mesangial cells treated
with high glucose
Diverse pathways of apoptosis regulation have been
proposed, but two canonical pathways are the extrinsic
or death receptor pathway and the intrinsic or mitochon-
drial pathway [30–32]. To identify the apoptotic signaling
pathways activated by high glucose in human mesangial
cells, Western blotting for the active fragment of caspase-
9 and caspase-8 was performed. High glucose stimulated
caspase-9 cleavage and release of the p35 kD active frag-
ment in cultured human mesangial cells (Fig. 2). The
p35 kD caspase-9 active fragment was detectable at
8 hours and increased progressively up to 72 hours
(Fig. 2B). Cells cultured in normal glucose had no de-
tectable p35 kD active fragment. The increase in caspase-
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Fig. 3. High glucose increases caspase-9 enzyme activity in human
mesangial cells. Cells incubated in high glucose (HG) for the times
indicated were lysed, and caspase-9 enzyme activity (i.e., LEHDase ac-
tivity) was measured using equivalent amounts of human mesangial cell
protein. Enzyme activity measured as relative light units was normal-
ized relative to caspase-9 activity at 0 time in normal glucose. ∗P < 0.05;
∗∗P < 0.01 by one-way analysis of variance (ANOVA) with Bonferroni
post hoc test vs. control (three independent experiments in duplicate).
9 by high glucose paralleled the decline in human
mesangial cell viability observed in Figure 1. In contrast,
high glucose did not detectably increase levels of the p40
kD active fragment of caspase-8, the major initiator cas-
pase of the death receptor pathway of apoptotic signal-
ing (Fig. 2A). Because caspase-9 is an important initia-
tor caspase in the intrinsic pathway, these results sug-
gest that high glucose stimulates the intrinsic pathway
of proapoptotic signaling in human mesangial cells. This
conclusion was further supported by enzymatic analysis
of caspase-9 activity in extracts from human mesangial
cells treated with high glucose (Fig. 3), which showed el-
evation of caspase-9 activity (i.e., LEHDase activity) as
early as 8 hours after addition of high glucose. Caspase-9
activity in cells treated with high glucose was also elevated
at 24 and 48 hours (Fig. 3).
The intrinsic pathway of apoptotic signaling involves
release of multiple polypeptides from mitochondria
and formation of the apoptosome containing activated
caspase-9. Release of cytochrome-c from mitochondria
is a key event in the initiation and regulation of apoptosis
through the caspase-9–dependent intrinsic pathway. In-
cubation of human mesangial cells with normal glucose
for up to 24 hours caused no detectable redistribution of
cytochrome-c from membrane-bound to cytosolic frac-
tions (Fig. 4). High glucose rapidly stimulated release of
cytochrome-c into the cytosol (Fig. 4). Cytosolic levels
of cytochrome-c remained elevated for up to 24 hours in
cells treated with high glucose. These results are consis-
tent with activation of an intrinsic pathway of apoptosis
signaling by high glucose.
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Fig. 4. High glucose elevates cytosolic levels of cytochrome-c in human
mesangial cells. (A) Translocation of p14 kD cytochrome-c to the cytosol
was measured by Western blotting of cells fractionated into cytosol (top
panel) and membrane-bound (bottom panel) preparations by digitonin.
Equivalent amounts of either the cytosol or membrane-bound fractions
from cells treated with normal glucose (NG) or high glucose (HG) were
loaded in each lane. (B) Densitometric analysis of p14 cytochrome-c
levels in cytosolic fractions from three independent experiments. ∗∗P <
0.01 by t test vs. normal glucose at same time.
To determine the functional role of caspase-9 in high
glucose–mediated apoptosis in human mesangial cells,
cells were treated with a cell-permeable caspase-9 selec-
tive inhibitor, Z-LEHD-FMK. As shown in Figure 5A,
treatment with high glucose for 24 hours increased the
level of p17-p19 active caspase-3; normal glucose had no
effect. Coincubation with Z-LEHD-FMK prevented the
increase in active caspase-3 by high glucose (Fig. 5A). Z-
LEHD-FMK also blocked the increase in pyknotic nuclei
observed in cells treated with high glucose (Fig. 5B). Col-
lectively, these results support a role for caspase-9 and
the intrinsic signaling pathway in the proapoptotic action
of high glucose in cultured human mesangial cells.
Apoptosis in db/db diabetic kidneys
To further investigate the possible relevance of apop-
totic signaling in glomerular injury in vivo, we studied
apoptosis in the db/db murine model of kidney injury in
type 2 diabetes [25]. Table 1 presents the metabolic and
renal parameters of the 8- and 16-week db/db mice used
in these studies. Hyperglycemia was evident in 8- and
16-week db/db but not db/m mice. Albuminuria was
higher in 8-week db/db compared to db/m mice, but the
mesangial matrix fraction was normal compared to the
8-week db/m controls (Table 1). At 16 weeks, the hyper-
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Fig. 5. Inhibition of caspase-9 blocks apoptosis induced by high glucose
in cultured human mesangial cells. (A) Cells were treated for 24 hours
with normal glucose (NG) or high glucose (HG) in the absence or pres-
ence of 40 lmol/L Z-LEHD-FMK to inhibit caspase-9 (C9I). The levels
of p17 and p19 kD cleaved caspase-3 (upper panel) were measured by
Western blotting. Inhibition of caspase-3 cleavage by Z-LEHD-FMK
was observed in two independent experiments. (B) Human mesangial
cells treated with high glucose as in (A) were fixed, stained with Hoechst
33342, and the percentage of pyknotic nuclei were counted. ∗∗P < 0.01
by v 2 test.
glycemic db/db mice manifested evidence of renal injury
including increments in albuminuria, mesangial matrix
fraction, and serum creatinine (Table 1). These results
confirm that 8-week db/db mice have relatively normal re-
nal histology despite hyperglycemia and albuminuria and
that 16-week db/db mice elaborate significant glomerular
damage.
As a first step in determining whether an apoptotic sig-
naling cascade had been initiated in db/db kidneys, we
assessed caspase-3 cleavage in extracts of 8- and 16-week
db/m and db/db kidneys. As shown in Figure 6, the p19 kD
cleaved active fragment of murine caspase-3 was elevated
in 16-week db/db kidneys. Longer exposures of the West-
ern blots revealed a modest increase in p19 in the 8-week
db/db kidneys but no detectable p19 in the 8- or 16-week
db/m kidneys (data not shown). However, the amount of
the active fragment of caspase-3 was always much higher
in the 16-week db/db kidneys. These results demonstrate
that caspase-3 is specifically activated in the diabetic kid-
ney. Activation of caspase-3 in the 16-week db/db kidney
was associated with the appearance of mesangial matrix
expansion (Table 1).
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Table 1. Metabolic and renal parameters in 8- and 16-week db/m and db/db mice
8-week db/m 8-week db/db 16-week db/m 16-week db/db
Body weight g 25.9 ± 3.3 36.4 ± 2.6a 28.9 ± 0.9 42.8 ± 1.3a,b
Blood glucose mg/dL 116 ± 5 389 ± 32a 168 ± 9 486 ± 23a,b
Kidney weight mg 168 ± 12 212 ± 15a 173 ± 9 232 ± 17a
Albuminuria lg/24 hours 0.9 ± 0.4 12.8 ± 3.8a 1.8 ± 1.6 35.1 ± 6.9a,b
Serum creatinine mg/dL 0.38 ± 0.17 0.41 ± 0.2 0.35 ± 0.7 0.53 ± 0.7a,b
Mesangial matrix fraction% 3.9 ± 1.4 4.9 ± 0.9 5.7 ± 3.2 12.8 ± 3.1a,b
Data are mean ± SD for five db/m and five db/db mice at each time. Statistical significance calculated using one-way analysis of variance (ANOVA) and Bonferroni
post hoc test.
aP < 0.05 vs. corresponding db/m.
bP < 0.05 vs. 8-week db/db.
Additional support for apoptosis in the diabetic kid-
neys comes from our studies of the effector caspase-7,
which is an important substrate for active caspase-3. We
used an antibody that specifically recognizes the p20 kD
active fragment of caspase-7 to evaluate caspase-7 activ-
ity in db/db kidneys (Fig. 6). The 20 kD cleaved frag-
ment of caspase-7 was present only in 8- and 16-week
db/db kidney extracts but not in extracts from the db/m
nondiabetic kidneys. Long exposures failed to detect the
p20 kD cleavage product in db/m extracts (data not
shown). The presence of active caspase-3 and -7 in db/db
but not db/m kidneys provides evidence that an apop-
totic signaling cascade has been initiated in the diabetic
kidneys.
The intrinsic pathway of apoptotic signaling in db/db
kidneys
We next analyzed the pathways of apoptotic signaling
in db/db mouse kidneys. As shown in Figure 7, caspase-
9 is activated in db/db mice as revealed by process-
ing of murine procaspase-9 (p47 kD) to the p39 and
p37 kD active fragments. The p39 and p37 kD frag-
ments were observed exclusively in db/db kidneys and
never in the nondiabetic db/m controls (Fig. 7). We also
noted that the steady-state level of procaspase-9 was
higher in the db/db mice, which is consistent with the
2.6-fold increase in caspase-9 mRNA observed in our
previous microarray studies [23]. These findings suggest
that diabetes causes an increase in kidney expression of
the procaspase-9 gene. Immunoblotting for b-actin con-
firmed that equal amounts of kidney protein were present
in each lane, which further supports that notion that
steady-state caspase-9 protein is elevated in the db/db
kidneys (Fig. 7).
Caspase-8 is the major initiator caspase of death
receptor-mediated pathway but the p40 and p23 kD ac-
tive caspase-8 fragments were undetectable in the db/db
kidney extracts (Fig. 7). In separate experiments, we con-
firmed that the caspase-8 antisera correctly detected the
p40 and p23 kD active fragment in Jurkat cells stimulated
by etoposide to induce apoptosis (not shown). We also
asked whether diabetes activates an apoptotic regulatory
pathway initiated by stress in the endoplasmic reticulum
stress. A pathway involving activation of procaspase-12
in the endoplasmic reticulum, presumably in response
to endoplasmic reticulum stress, was recently described
in murine cells [33]. Using an antibody that recognizes
the full-length and cleaved form of murine caspase-12,
we did not observe a difference in caspase-12 activa-
tion in db/db kidneys; however, a small amount of the
42 kD cleavage fragment was observed in all the lysates
and might reflect nonspecific proteolysis in the extrac-
tion procedure (Fig. 7). Alternatively, a small amount of
constitutive caspase-12 activity might be present in both
db/db and db/m kidneys. Taken together, our preliminary
results provide strong support for the hypothesis that dia-
betes activates apoptosis in the db/db kidneys by evoking
the intrinsic pathway of apoptotic signaling.
To further test the hypothesis that diabetes initiates
the intrinsic pathway of apoptosis in diabetes, we asked
whether Bax levels were higher in db/db kidneys. Bax
is a critical regulator of apoptosis induced by mitochon-
drial stress through the intrinsic pathway. Bax increases
permeability of the mitochondrial membrane leading to
release of cytochrome c, formation of the apoptosome,
and activation of caspase-9 [30]. Immunoblotting demon-
strated that although some p20 kD Bax protein was
detected in db/m kidney extracts, Bax protein was con-
sistently elevated in db/db vs. db/m mice (Fig. 8) These
results provide further support for apoptotic signaling
through the intrinsic pathway in db/db diabetic mouse
kidney.
Apoptosis in glomerular cells of the db/db kidney
Because the glomerular microvasculature is a ma-
jor site of injury in the diabetic kidney, our next goal
was to determine whether apoptosis was occurring in
glomeruli of db/db mice. Nuclear segmentation and DNA
fragmentation were assessed to identify apoptotic cells.
Nuclear morphology in glomeruli of hematoxylin-eosin–
stained sections from 16-week db/m controls were nor-
mal (Fig. 9A and C). In contrast, numerous apoptotic
changes were observed in the nuclei of glomerular cells
of 16-week db/db glomeruli (Fig. 9B and D). Many
apoptotic nuclei that displayed prototypical signs of
apoptosis, including segmentation and condensation
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Fig. 6. Caspases-3 and -7 are activated specifically in db/db kidneys.
(A) Kidney extracts containing equal amounts of protein were analyzed
by Western blotting for caspase-3 activation using an antibody that rec-
ognizes a “neoepitope” in the cleaved (C) 19 kD murine casapse-3 active
fragment. To determine if caspase-7 was activated in db/db kidneys, we
performed Western blots with an anticleaved caspase-7 (Asp198) an-
tibody that detects endogenous levels of the large active fragment (p
20 kD) of caspase-7 resulting from cleavage at aspartic acid 198. This
antibody does not crossreact with full-length caspase-7 or with other
caspases. The blot was reprobed with an antibody that recognizes b-
actin to confirm equal protein loading (bottom panel). Two different
mouse kidney extracts have been presented at each time point (lanes
1 and 2). (B) Densitometric analysis of Western blots for the active
caspase-7 fragment in extracts prepared from five mice per condition.
∗∗P < 0.01 by one-way analysis of variance (ANOVA) with Bonferroni
post hoc test vs. db/m.
(Fig. 9D, arrows) appeared to be in the mesan-
gial/endocapillary regions, but a definitive assignment of
cell type can not be made from these studies. Impor-
tantly, apoptotic nuclear changes were only rarely ob-
served in the glomeruli of 8-week db/db kidneys and were
not present in the nondiabetic db/m mice at any time.
Another indicator of apoptosis (DNA fragmenta-
tion) was assessed by TUNEL staining in paraffin-
embedded sections. TUNEL-positive nuclei were ob-
served in glomeruli of 16-week db/db kidneys (Fig. 9E
and F, arrows) (8-week db/m, 0.2 ± 0.1; 8-week db/db,
0.6 ± 0.3; 16-week db/m, 0.4 ± 0.3; 16-week db/db,
2.7 ± 0.6; data are mean ± SEM, P < 0.01 by Student
t test versus 16-week db/m). Controls in the TUNEL as-
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Fig. 7. Caspase-9 is activated in db/db diabetic kidneys. (A) Kid-
neys from db/db and db/m kidneys were homogenized, and equivalent
amounts of tissue protein were analyzed by Western blotting. Specific
antibodies were used that recognize the procaspase (P) and cleaved
(C) forms of murine caspase-9, murine caspase-8, and murine caspase-
12. b-actin was used as a control for protein loading. The position and
molecular weight of the procasapse and cleaved caspase are indicated.
Each lane represents a different mouse kidney extract from each group
(i.e., lanes 1 and 2). (B) Densitometric analysis of the active caspase-9
fragment by Western blots performed on five mice per condition. ∗∗P <
0.01 by one-way analysis of variance (ANOVA) with Bonferroni post
hoc test vs. db/m.
say included nuclease-treated sections to ensure the ad-
equacy of proteinase-k digestion (Fig. 9G) and omission
of the TdT enzyme (Fig. 9H). Collectively, the results
demonstrate that apoptosis is occurring in glomerular
cells of 16-week db/db mice. In addition, apoptosis of
glomerular cells correlates with mesangial matrix expan-
sion and worsening of albuminuria in 16-week db/db mice
(Table 1).
DISCUSSION
Chronic hyperglycemia causes cell stress and apop-
tosis in the microvasculature, but the proapoptotic
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Fig. 8. Bax protein is specifically elevated in the diabetic compared
to the nondiabetic kidneys. (A) Equivalent amounts of kidney protein
were analyzed for Bax by Western blotting. The antibody specifically
recognizes the full-length p20 kD protein, which was elevated in the dia-
betic kidneys. Modest levels of p20 were observed in the 8- and 16-week
db/m kidneys but were always lower than levels in the corresponding
db/db mice. Lanes 1 and 2 represent two different mice in each con-
dition. (B) Densitometric analysis of p20 Bax levels from a total of
five mice in each group. ∗∗P < 0.01 by one-way analysis of variance
(ANOVA) with Bonferroni post hoc test vs. db/m.
signal transduction pathways evoked by high glucose
are unclear. Our results support the hypothesis that hy-
perglycemia evokes an intrinsic mitochondrial pathway
of proapoptotic signal transduction in cultured human
mesangial cells. In addition, an intrinsic pathway of apop-
totic signaling is activated in diabetic murine kidneys and
is associated with apoptosis of glomerular cells in vivo.
Proapoptotic signaling pathways in mesangial cells
exposed to high glucose and in diabetic kidney injury
in vivo
Consistent with results from a previous study [9], we
found that exposure to high glucose increased apop-
tosis and reduced mesangial cell viability. In support
of a role for the intrinsic pathway in hyperglycemia-
induced mesangial cell apoptosis, the cleaved fragment
of procaspase-9, which reflects activation of caspase-9 in
the intrinsic pathway, was present only in the cells ex-
posed to high glucose and was never observed in the cells
exposed to normal glucose. Caspase-9 enzyme activity
was also activated specifically by high glucose. In human
mesangial cells, high glucose failed to activate caspase-8,
a key initiator caspase in the death receptor pathway. In
addition, mitochondrial release of cytochrome-c, which
helps form the apoptosome to activate caspase-9 in the
intrinsic pathway, was observed only in human mesangial
cells exposed to high glucose. Most important, a selec-
tive caspase-9 inhibitor blocked both caspase-3 activity
and formation of pyknotic nuclei in cells exposed to high
glucose. Collectively, these results demonstrate that high
glucose stimulates apoptosis in human mesangial cells by
activating an intrinsic pathway of proapoptotic signaling.
Several lines of evidence suggested that an intrinsic
pathway of apoptotic signaling was also activated in the
kidney of db/db mice, a model for glomerular injury in
type 2 diabetes. Caspase-9 but not caspase-8 was elevated
exclusively in the diabetic kidneys. Although endoplas-
mic reticulum stress, particularly in response to protein
unfolding, seems to be a possible pathway for cell injury
in diabetes, we did not observe an increase of caspase-12
processing in the db/db kidneys. However, the paucity of
information regarding a procaspase-12 homolog in hu-
man cells makes the importance of this pathway diffi-
cult to evaluate. Two downstream effector caspases of
caspase-9, caspase-3 and caspase-7, were also stimulated
in db/db kidneys. Bax protein was increased in the db/db
kidneys, consistent with an intrinsic pathway of regula-
tion. Ortiz, Ziyadeh, and Neilson [34] have reported ele-
vated Bax mRNA in the renal cortex of db/db mice, and
Murata et al [35] have previously demonstrated increased
Bax in the kidneys of the Otsuka Long-Evans Tokushima
Fatty rats, another experimental model of type 2 dia-
betes. Although our studies of caspase activation by West-
ern blotting were performed on whole kidney extracts,
the results are presumably relevant to apoptosis in the
glomerular cells because the vast majority of apoptosis in
the 16-week db/db kidneys was detected in the glomeru-
lus, not in the renal tubules. However, considerable work
remains to be done to identify the relevant stimuli of the
intrinsic pathway in the diabetic kidney in vivo. Hyper-
glycemia in db/db mice is prominent, but we can not rule
out activation by other known apoptotic stimuli, includ-
ing AGEs, which have been widely implicated in diabetic
microvascular complications. In addition, TGF-b causes
apoptosis in specific cell types, and this cytokine is ele-
vated in db/db kidneys [36]. Administration of TGF-b–
neutralizing antisera retards the progression of glomeru-
lar injury in these mice [37, 38], so it would be important
to determine whether TGF-b could initiate the intrinsic
pathway of apoptotic signaling in glomeruli in vivo.
Apoptosis in glomerular cells of the db/db kidney
An important implication of our study is that the intrin-
sic pathway of apoptotic signaling could lead to glomeru-
lar injury in the kidney in diabetes. A previous study in
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Fig. 9. Localization of apoptotic cells to the
glomeruli of 16-week db/db mice. Represen-
tative hematoxylin-eosin staining of (A) 16-
week db/m nondiabetic control kidney and
(B) 16-week db/db diabetic kidneys. The mag-
nified insets from (A) and (B) are shown in (C)
and (D), respectively. Histologic hallmarks
of apoptosis, including condensation of nu-
clear chromatin and segmentation of the nu-
clei (D, arrows), were evident in glomeruli
of db/db kidneys but not in the db/m con-
trols. Terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate (dUTP)
nick end labeling (TUNEL) identifies DNA
fragmentation, an important characteristic of
apoptotic cells, and is evident in glomeruli
of 16-week db/db glomeruli (E and F, ar-
rows). The TUNEL-stained sections were
counterstained with methyl green. (G) TACS-
nuclease-treated controls were performed in
each assay to confirm sufficient permeabi-
lization as were (F) unlabeled experimental
controls [i.e., omission of terminal deoxynu-
cleotidyl transferase (TdT)]. Both (G and H)
are representative glomeruli from 16-week
db/db mice. All measurements of TUNEL
staining in db/db kidneys were conducted con-
currently with identically processed db/m con-
trols (magnification ×400).
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db/db mice [34] showed that Bcl-2 mRNA was decreased
while Bax mRNA was elevated in the renal cortex of
db/db mice, which is consistent with a pro-apoptotic phe-
notype. In addition, a study by Bamri-Ezzine et al [39]
showed caspase-3 activation in the kidneys of rats in-
jected with streptozotocin to cause diabetes. High glu-
cose causes atrophy and apoptosis in the metanephric
mesenchyme [40], which also suggests that hyperglycemia
induces apoptosis in the kidney. Murata et al [35] found
glomerular cell apoptosis in a rat model of type 2 diabetes,
and Pesce et al [41] observed TUNEL-positive glomeru-
lar cells in long-term (6 months) streptozotocin-injected
rats. Thus, our present results are consistent with previous
reports that diabetes results in apoptosis of glomerular
cells in vivo.
Although our present results and the existing literature
do not prove a pathogenic role for apoptosis in glomeru-
lar injury, clinical studies of patients with type 2 diabetes
are consistent with this hypothesis. Evidence to support
this idea comes from several studies by Pagtalunan et al
[13], Meyer, Bennet, and Nelson [14], and Lemley et al
[15], in which a reduction in the number of podocytes cor-
relates with proteinuria and glomerular structural dam-
age in humans with diabetic nephropathy. In fact, the loss
of glomerular podocytes is an excellent predictor of renal
disease progression [14]. Another recent study by Dalla
Vestra et al [16] shows loss of podoyctes in type 2 diabet-
ics and that the density of podocytes per glomerulus was
inversely correlated with the rate of albumin excretion.
Loss of podocytes has also been reported in patients with
diabetic nephropathy secondary to type 1 diabetes [42,
43]. Also in humans with type 2 diabetes, loss of mesan-
gial cells correlates with the development of incipient
nephropathy and with significant structural changes re-
sulting in the loss of single nephron Kf [15]. It is impor-
tant to note that these clinical studies did not investigate
the mechanism of mesangial and epithelial cell death, but
it seems possible that apoptosis is in part responsible for
this loss of podoctyes and mesangial cells in the diabetic
kidney. Apoptotic death of podocytes and mesangial cells
might be especially deleterious given the low replicative
capacity of these glomerular cells in vivo.
CONCLUSION
Our results support the hypothesis that hyperglycemia
activates an intrinsic pathway of proapoptotic signaling
in mesangial cells and that the intrinsic pathway is acti-
vated in db/db kidneys in vivo. Studies are now needed
to confirm these results in other experimental models of
diabetic kidney injury, to determine whether antidiabetic
therapies might act in part by attenuating glomerular cell
apoptosis, and particularly to see if specific inhibition of
the intrinsic pathway of apoptosis reduces the progres-
sion of renal injury in experimental models of diabetes.
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